Gene27240
SIT1: signaling threshold regulating transmembrane adaptor 1
Cite this record
ConductScience Library. SIT1: signaling threshold regulating transmembrane adaptor 1. Genes, record 27240. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/27240
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9Y3P8 | Signaling threshold-regulating transmembrane adapter 1 | 196 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents87
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260226133 A1 | 2026-08-06 | 8939 | Q9Y3P8 | Espacenet |
| US 20260227408 A1 | 2026-08-06 | 78 | Q9Y3P8 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 1347 | Q9Y3P8 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 3973 | Q9Y3P8 | Espacenet |
| JP 2026501516 A | 2026-01-16 | 8939 | Q9Y3P8 | Espacenet |
| US 20260015401 A1 | 2026-01-15 | 1436 | Q9Y3P8 | Espacenet |
| EP 4646428 A1 | 2025-11-12 | 8939 | Q9Y3P8 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1347 | Q9Y3P8 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 78 | Q9Y3P8 | Espacenet |
| KR 1020250133399 A | 2025-09-05 | 8939 | Q9Y3P8 | Espacenet |
NIH grants287
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SIT1 papers | Newest fiscal year |
|---|---|---|---|
| P50CA121974 | Yale SPORE in Skin Cancer | 3 | 2025 |
| P30AR069625 | Human Skin Disease Resource-based Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA054174 | Mays Cancer Center at UT Health SA | 2 | 2025 |
| P30CA076292 | Moffitt Cancer Center Support Grant | 2 | 2025 |
| R01AI125640 | Novel mechanisms regulating PD-1 signaling and function | 2 | 2025 |
| IK6BX004851 | BLR&D Research Career Scientist Award | 1 | 2025 |
| KL2TR001862 | Institutional Career Development Core | 1 | 2025 |
| P01AI039671 | Costimulatory Mechanisms of Autoimmunity | 1 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 1 | 2025 |
Source NIH's project files
Papers440
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Immune Response-Related Proteomic Biomarkers in Moyamoya Disease Using Serum Olink Proteomics. | J Proteome Res | 2026 | 42695863 | PubTator, text mining | PubMed |
| Decision Tree Prediction of Saline Infusion Test Outcomes in Suspected Primary Aldosteronism: A Multicenter CDM Study. | J Clin Endocrinol Metab | 2026 | 42573165 | PubTator, text mining | PubMed |
| Development and initial validation of a Structured Interview for Temperament and Character (SIT-C). | BMC Psychol | 2026 | 42323697 | PubTator, text mining | PubMed |
| Homozygous loss-of-function mutation in SIT1 leads to combined immunodeficiency due to dysregulated T-cell receptor signaling. | J Allergy Clin Immunol | 2026 | 42128181 | PubTator, text mining | PubMed |
| Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. | Signal Transduct Target Ther | 2026 | 41912482 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinoma. | Exp Hematol Oncol | 2026 | 41612507 | PubTator, text mining | PubMed |
| Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort. | Transplant Cell Ther | 2026 | 41033605 | PubTator, text mining | PubMed |
| Mechanisms involved in aminoacidurias: impacts of genetic and environmental factors. | Curr Res Physiol | 2025 | 41142409 | PubTator, text mining | PubMed |
| Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids. | Nat Commun | 2025 | 41006208 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/27240
GET https://conductscience.org/api/genes/v1/27240/patents?page=2